Value Aligned Research Advisors LLC raised its stake in BKV Corporation (NYSE:BKV – Free Report) by 110.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 679,899 shares of the company’s stock after acquiring an additional 356,848 shares during the quarter. Value Aligned Research Advisors LLC owned approximately 0.62% of BKV worth $18,602,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. SBI Okasan Asset Management Co.Ltd. acquired a new stake in shares of BKV during the fourth quarter valued at $52,000. Police & Firemen s Retirement System of New Jersey raised its stake in BKV by 34.3% in the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 5,701 shares of the company’s stock valued at $155,000 after purchasing an additional 1,455 shares during the last quarter. PEAK6 LLC purchased a new position in BKV in the 2nd quarter valued at about $270,000. Jupiter Topco LLC purchased a new position in BKV in the 2nd quarter valued at about $446,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of BKV during the 2nd quarter worth about $479,000.
BKV Stock Performance
Shares of BKV stock opened at $26.04 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.10 and a current ratio of 1.15. The firm has a market capitalization of $2.85 billion, a price-to-earnings ratio of 9.50 and a beta of 1.06. BKV Corporation has a one year low of $20.08 and a one year high of $32.81. The company has a 50 day moving average price of $25.47 and a 200 day moving average price of $27.26.
Insider Activity
In other news, SVP Javier Hinojosa sold 12,377 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $25.73, for a total transaction of $318,460.21. Following the completion of the sale, the senior vice president owned 84,276 shares in the company, valued at approximately $2,168,421.48. The trade was a 12.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Lindsay Larrick sold 10,000 shares of the stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $26.16, for a total transaction of $261,600.00. Following the sale, the insider directly owned 83,925 shares of the company’s stock, valued at approximately $2,195,478. This trade represents a 10.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 28,198 shares of company stock valued at $733,271 in the last three months. Corporate insiders own 2.51% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on BKV. Citigroup cut their price objective on shares of BKV from $36.00 to $33.00 and set a “buy” rating for the company in a research report on Thursday, June 11th. Wall Street Zen lowered shares of BKV from a “sell” rating to a “strong sell” rating in a research report on Saturday. Truist Financial lowered their target price on shares of BKV from $34.00 to $33.00 and set a “buy” rating for the company in a research note on Monday, August 10th. Susquehanna reduced their price target on BKV from $37.00 to $35.00 and set a “positive” rating on the stock in a research note on Tuesday, July 21st. Finally, Barclays increased their price target on BKV from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 11th. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, BKV has a consensus rating of “Moderate Buy” and a consensus price target of $34.25.
Check Out Our Latest Report on BKV
BKV Company Profile
BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas. BKV Corporation, LLC operates as a subsidiary of Banpu North America Corporation.
Further Reading
- Five stocks we like better than BKV
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding BKV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BKV Corporation (NYSE:BKV – Free Report).
Receive News & Ratings for BKV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BKV and related companies with MarketBeat.com's FREE daily email newsletter.
